Effectiveness and safety of insulin glargine Gla-300 in insulin-naïve type 2 diabetes subjects in a real-life setting—the GOAL_RO trial

BACKGROUND: Basal insulin is the first choice for insulin initiation in type 2 diabetes (T2DM), with the second generation of basal insulin analogues having a lower risk of hypoglycemia compared to the first generation of basal insulins. The aim of our study was to assess on a large cohort of insuli...

Descripción completa

Detalles Bibliográficos
Autores principales: Stegaru, Daniela, Nicodim, Simona, Vladu, Delia, Guțu, Olimpia, Onaca, Adriana, Pîrvu, Florina, Moise, Mihaela, Guja, Cristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867914/
https://www.ncbi.nlm.nih.gov/pubmed/33569407
http://dx.doi.org/10.21037/atm-20-4533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867914/
https://www.ncbi.nlm.nih.gov/pubmed/33569407
http://dx.doi.org/10.21037/atm-20-4533

Ejemplares similares